1. Home
  2. DOUG vs QTRX Comparison

DOUG vs QTRX Comparison

Compare DOUG & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Elliman Inc.

DOUG

Douglas Elliman Inc.

HOLD

Current Price

$1.67

Market Cap

178.2M

Sector

Real Estate

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.02

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOUG
QTRX
Founded
1911
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Laboratory Analytical Instruments
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
178.2M
160.0M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
DOUG
QTRX
Price
$1.67
$3.02
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
414.0K
818.8K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
118.68
N/A
EPS
N/A
N/A
Revenue
$955,578,000.00
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
N/A
$10.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.52
52 Week Low
$1.53
$2.15
52 Week High
$3.19
$8.77

Technical Indicators

Market Signals
Indicator
DOUG
QTRX
Relative Strength Index (RSI) 37.68 54.24
Support Level $1.68 $2.89
Resistance Level $1.84 $3.25
Average True Range (ATR) 0.06 0.19
MACD -0.01 0.08
Stochastic Oscillator 15.00 79.27

Price Performance

Historical Comparison
DOUG
QTRX

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: